IBDEI1BV ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22570,2)
 ;;=^5063369
 ;;^UTILITY(U,$J,358.3,22571,0)
 ;;=Z82.5^^87^982^22
 ;;^UTILITY(U,$J,358.3,22571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22571,1,3,0)
 ;;=3^Family Hx of Asthma/Chronic Lower Respiratory Diseases
 ;;^UTILITY(U,$J,358.3,22571,1,4,0)
 ;;=4^Z82.5
 ;;^UTILITY(U,$J,358.3,22571,2)
 ;;=^5063370
 ;;^UTILITY(U,$J,358.3,22572,0)
 ;;=Z82.61^^87^982^21
 ;;^UTILITY(U,$J,358.3,22572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22572,1,3,0)
 ;;=3^Family Hx of Arthritis
 ;;^UTILITY(U,$J,358.3,22572,1,4,0)
 ;;=4^Z82.61
 ;;^UTILITY(U,$J,358.3,22572,2)
 ;;=^5063371
 ;;^UTILITY(U,$J,358.3,22573,0)
 ;;=Z82.69^^87^982^44
 ;;^UTILITY(U,$J,358.3,22573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22573,1,3,0)
 ;;=3^Family Hx of Musculoskeletal System/Connective Tissue
 ;;^UTILITY(U,$J,358.3,22573,1,4,0)
 ;;=4^Z82.69
 ;;^UTILITY(U,$J,358.3,22573,2)
 ;;=^5063373
 ;;^UTILITY(U,$J,358.3,22574,0)
 ;;=Z83.3^^87^982^28
 ;;^UTILITY(U,$J,358.3,22574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22574,1,3,0)
 ;;=3^Family Hx of Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,22574,1,4,0)
 ;;=4^Z83.3
 ;;^UTILITY(U,$J,358.3,22574,2)
 ;;=^5063379
 ;;^UTILITY(U,$J,358.3,22575,0)
 ;;=Z83.2^^87^982^24
 ;;^UTILITY(U,$J,358.3,22575,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22575,1,3,0)
 ;;=3^Family Hx of Blood/Immune Mechanism Diseases
 ;;^UTILITY(U,$J,358.3,22575,1,4,0)
 ;;=4^Z83.2
 ;;^UTILITY(U,$J,358.3,22575,2)
 ;;=^5063378
 ;;^UTILITY(U,$J,358.3,22576,0)
 ;;=Z82.71^^87^982^47
 ;;^UTILITY(U,$J,358.3,22576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22576,1,3,0)
 ;;=3^Family Hx of Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,22576,1,4,0)
 ;;=4^Z82.71
 ;;^UTILITY(U,$J,358.3,22576,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,22577,0)
 ;;=Z82.1^^87^982^23
 ;;^UTILITY(U,$J,358.3,22577,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22577,1,3,0)
 ;;=3^Family Hx of Blindness/Visual Loss
 ;;^UTILITY(U,$J,358.3,22577,1,4,0)
 ;;=4^Z82.1
 ;;^UTILITY(U,$J,358.3,22577,2)
 ;;=^5063365
 ;;^UTILITY(U,$J,358.3,22578,0)
 ;;=Z82.2^^87^982^27
 ;;^UTILITY(U,$J,358.3,22578,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22578,1,3,0)
 ;;=3^Family Hx of Deafness/Hearing Loss
 ;;^UTILITY(U,$J,358.3,22578,1,4,0)
 ;;=4^Z82.2
 ;;^UTILITY(U,$J,358.3,22578,2)
 ;;=^5063366
 ;;^UTILITY(U,$J,358.3,22579,0)
 ;;=Z84.0^^87^982^48
 ;;^UTILITY(U,$J,358.3,22579,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22579,1,3,0)
 ;;=3^Family Hx of Skin Diseases
 ;;^UTILITY(U,$J,358.3,22579,1,4,0)
 ;;=4^Z84.0
 ;;^UTILITY(U,$J,358.3,22579,2)
 ;;=^5063388
 ;;^UTILITY(U,$J,358.3,22580,0)
 ;;=Z82.79^^87^982^26
 ;;^UTILITY(U,$J,358.3,22580,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22580,1,3,0)
 ;;=3^Family Hx of Congen Malform,Deformations & Chromsoml Abnlt
 ;;^UTILITY(U,$J,358.3,22580,1,4,0)
 ;;=4^Z82.79
 ;;^UTILITY(U,$J,358.3,22580,2)
 ;;=^5063374
 ;;^UTILITY(U,$J,358.3,22581,0)
 ;;=Z84.89^^87^982^46
 ;;^UTILITY(U,$J,358.3,22581,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22581,1,3,0)
 ;;=3^Family Hx of Other Spec Conditions
 ;;^UTILITY(U,$J,358.3,22581,1,4,0)
 ;;=4^Z84.89
 ;;^UTILITY(U,$J,358.3,22581,2)
 ;;=^5063393
 ;;^UTILITY(U,$J,358.3,22582,0)
 ;;=Z81.1^^87^982^20
 ;;^UTILITY(U,$J,358.3,22582,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22582,1,3,0)
 ;;=3^Family Hx of Alcohol Abuse/Dependence
 ;;^UTILITY(U,$J,358.3,22582,1,4,0)
 ;;=4^Z81.1
 ;;^UTILITY(U,$J,358.3,22582,2)
 ;;=^5063359
 ;;^UTILITY(U,$J,358.3,22583,0)
 ;;=Z82.62^^87^982^45
 ;;^UTILITY(U,$J,358.3,22583,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22583,1,3,0)
 ;;=3^Family Hx of Osteoporosis
